Literature DB >> 3087668

Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation.

D E Griffin, T R Moench, R T Johnson, I Lindo de Soriano, A Vaisberg.   

Abstract

Peripheral blood mononuclear cells from 25 patients with measles and 13 patients with other diseases from Lima, Peru, were studied by immunocytochemical staining for cell surface antigens indicating the type of cell (Leu 4, Leu 3, T8, B1, M1, or esterase) and the state of cell activation (T10 and IL-2 receptor). Measles patients were studied during the first 2 weeks of disease and had no alteration in the proportion of cells which were positive for any subset marker or in the ratio of helper/inducer to cytotoxic/suppressor T cells compared to controls. Measles patients, however, had a greater number of cells expressing the activation antigens T10 and IL-2 receptor than controls. Incorporation of [3H]thymidine was also higher in measles patients when exogenous natural or recombinant IL-2 was added to unstimulated cultured cells. We conclude that the peripheral blood mononuclear leukocytes of patients with measles have normal proportions of helper/inducer and cytotoxic/suppressor T lymphocytes, B lymphocytes, and monocytes but that an increased number of these cells are in an activated state.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087668     DOI: 10.1016/0090-1229(86)90035-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

Review 1.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

2.  Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression.

Authors:  J J Schnorr; S Xanthakos; P Keikavoussi; E Kämpgen; V ter Meulen; S Schneider-Schaulies
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 3.  Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity.

Authors:  P Imbach; J Akatsuka; V Blanchette; A Burek-Kozlowska; J Bussel; G Gaedicke; A Gianella-Borradori; E Gugler; A Hirt; B Imholz
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

4.  Natural killer cell activity during measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

Review 5.  Harmful and beneficial antibodies in immune thrombocytopenic purpura.

Authors:  P A Imbach
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

7.  The inflammatory cytokines in measles: correlation between serum interferon-gamma levels and lymphocyte subpopulations.

Authors:  S Ohga; C Miyazaki; K Okada; K Akazawa; K Ueda
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

8.  Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants.

Authors:  Hayley A Gans; Linda L Yasukawa; Cathryn Z Zhang; Rima Hanna Wakim; Mary Rinki; Ross Dehovitz; Ann M Arvin
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

9.  Interplay between virus-specific effector response and Foxp3 regulatory T cells in measles virus immunopathogenesis.

Authors:  Caroline I Sellin; Jean-François Jégou; Joëlle Renneson; Johan Druelle; T Fabian Wild; Julien C Marie; Branka Horvat
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

10.  Depletion of CD8+ T cells from vaccinated goats does not affect protection from challenge with wild-type peste des petits ruminants virus.

Authors:  Michael D Baron; Sophia Hodgson; Katy Moffat; Mehnaz Qureshi; Simon P Graham; Karin E Darpel
Journal:  Transbound Emerg Dis       Date:  2020-12-20       Impact factor: 4.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.